Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Endocrine 1

Conditions

Pheochromocytoma 1Endocrine System Diseases 1

Interventions

Specimen Handling 13Magnetic Resonance Spectroscopy 13lutetium Lu 177 dotatate 10cabozantinib 6Nivolumab 5X-Rays 4Ipilimumab 4Cisplatin 4pembrolizumab 3olaparib 3fludarabine 3Phantoms, Imaging 3Everolimus 3Etoposide 3Cyclophosphamide 3Carboplatin 3CTLA-4 Antigen 3gallium Ga 68 dotatate 2fluorodopa F 18 2aldesleukin 2Temozolomide 2Lutetium-177 2Lutetium 2Irinotecan 2Fluorodeoxyglucose F18 23-aminopyridine-2-carboxaldehyde thiosemicarbazone 2trametinib 1tipifarnib 1sodium thiosulfate 1selpercatinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
6-fluorodopamine × Endocrine × 30 days × Clear all
NCT00004847 2026-06-03

Diagnosis of Pheochromocytoma

National Institutes of Health Clinical Center (CC)

Phase 1 Recruiting
3,000 enrolled
Endocrine

Endocrine System Diseases, Pheochromocytoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡